MedPath

EFFICACY OF INJECTABLE PLATELET RICH FIBRIN ON ACCELERATING MOLAR DISTALISATION DURING EN MASSE RETRACTION USING INFRAZYGOMATIC CREST IMPLANTS -A RANDOMISED CONTROL TRIA

Phase 3
Conditions
Health Condition 1: M262- Anomalies of dental arch relationshipHealth Condition 2: M262- Anomalies of dental arch relationshipHealth Condition 3: K088- Other specified disorders of teethand supporting structures
Registration Number
CTRI/2022/11/047070
Lead Sponsor
Saveetha Dental College and Hospitals
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.PATIENTS REQUIRING IZC AIDED EN MASSE RETRACTION WITH EXTRACTION OF 8â??s

2.AGED -18-35 YEARS

3.NO SYSTEMIC ILLNESS, ABSENCE OF BONE METABOLIC DISORDERS.

4.PERIODONTALLY HEALTHY SUBJECTS.

5.GOOD ORAL HYGIENE.

6.PATIENTS WITHIN THE ACCEPTABLE UNIFORM RANGE OF BONE DENSITY.

Exclusion Criteria

1. PATIENTS WITH SYSTEMIC ILLNESS, BONE METABOLIC DISORDERS.

1.PERIODONTALLY COMPROMISED SUBJECTS.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rate of molar distalisationTimepoint: rate of molar distalisation at first, third and fifth month
Secondary Outcome Measures
NameTimeMethod
level of alkaline phosphatase and acid phosphatase in gingival crevicular fluid.Timepoint: start of retraction, end of five months.
© Copyright 2025. All Rights Reserved by MedPath